Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]

TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET...

Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA

TATTON: Osimertinib plus savolitinib for patients with EGFR-mutant, MET-amplified NSCLC after progression on EGFR-TKI ( Prof Lecia Sequist - Massachusetts General Hospital, Boston, USA )

Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1...

Dr James Gulley - National Cancer Institute, Bethesda, USA

Evaluation of M7824, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with HPV-associated malignancies ( Dr James Gulley - National Cancer Institute, Bethesda, USA )

The hereditary link between African-Americans and people in Africa and its...

Prof John Carpten - Keck School of Medicine, Los Angeles, USA

The hereditary link between African-Americans and people in Africa and its relationship to cancer incidence and outcomes ( Prof John Carpten - Keck School of Medicine, Los Angeles, USA )

Umbralisib as a monotherapy in patients with relapsed/refractory marginal zone...

Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA

$Umbralisib as a monotherapy in patients with relapsed/refractory marginal zone lymphoma ( Prof Nathan Fowler - MD Anderson Cancer Center, Houston, USA )$

Using regionally delivered autologous mesothelin-targeted CAR T cells in the...

Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA

Using regionally delivered autologous mesothelin-targeted CAR T cells in the treatment of malignant pleural disease ( Dr Prasad Adusumilli - Memorial Sloan Kettering Cancer Center, New York, USA )

Tumour shrinkage with ipilimumab plus nivolumab in patients with neuroendocrine...

Prof Sandip Patel - UC San Diego, San Diego, USA

Tumour shrinkage with ipilimumab plus nivolumab in patients with neuroendocrine carcinoma ( Prof Sandip Patel - UC San Diego, San Diego, USA )

Increased stroke risk in childhood cancer survivors

Dr Yadav Sapkota - St. Jude Children's Research Hospital, Memphis, USA

Increased stroke risk in childhood cancer survivors ( Dr Yadav Sapkota - St. Jude Children's Research Hospital, Memphis, USA )

KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases

Dr Marina Garassino - National Tumor Institute, Milan, Italy

KEYNOTE 189: Targeting NSCLC patients with brain and liver metastases ( Dr Marina Garassino - National Tumor Institute, Milan, Italy )

MYSTIC: Developing biomarkers for metastatic NSCLC

Prof Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne...

MYSTIC: Developing biomarkers for metastatic NSCLC ( Prof Solange Peters - Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland )

TATTON: Updated results for patients with EGFR-mutant NSCLC

Prof Leica Sequist - Massachusetts General Hospital, Boston, USA

TATTON: Updated results for patients with EGFR-mutant NSCLC ( Prof Leica Sequist - Massachusetts General Hospital, Boston, USA )

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity...

Prof Shoba Navai - Baylor College of Medicine, Houston, USA

HER2-targeted CAR T-cell therapy safe and showing promising antitumour activity in patients with advanced sarcoma ( Prof Shoba Navai - Baylor College of Medicine, Houston, USA )

Cancer preventive vaccine showed promising results in preclinical model of...

Prof Steven Lipkin - Weill Cornell Medical College, New York, USA

Cancer preventive vaccine showed promising results in preclinical model of Lynch syndrome ( Prof Steven Lipkin - Weill Cornell Medical College, New York, USA )

More from ecancer